• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number GSX0030A
Device Problem Material Separation (1562)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/01/2020
Event Type  malfunction  
Event Description
It was reported the physician was implanting a 30mm gore® cardioform septal occluder to close a patent foramen ovale.The physician attempted multiple times to cross the pfo with no success.They could not get the delivery catheter to cross the pfo over the guide wire.While attempting to remove the delivery catheter, it got stuck on the tip of the avanti 11fr introducer sheath.More force was applied, and the delivery catheter was removed.Upon inspection of the removed catheter it was noted that the radiopaque marker and guidewire port were missing from the tip of the delivery catheter.It was still on the guidewire just outside the tip of the introducer sheath.A balloon and larger sheath were used to remove the tip of the catheter without incident.A new 30mm device was implanted with no issues.The patient was doing well following the procedure.
 
Manufacturer Narrative
A review of the manufacturing records for the device verified that the lot met all pre-release specifications.
 
Manufacturer Narrative
The engineering investigation stated the following: the investigation revealed that a separation of the delivery catheter occurred near the distal end of the guidewire port.Inward deformation of the edges of the guidewire port and evidence of necking of the delivery catheter materials near the break are consistent with the application of significant tension along the length of the delivery catheter.The separated tip of the delivery catheter showed unraveling of the braid, frayed layers of the catheter and outward deformation of the distal edge of the guidewire port.The investigation also revealed that all other delivery system components including the sliding and locking mechanisms were unremarkable and that the size and shape of the occluder and lock loop were unremarkable.The findings of the investigation are consistent with the reporting of the event in that the delivery catheter was broken in tension, possibly due to interference between the tip of the delivery catheter and the 11fr avanti sheath (with possible guidewire involvement).However, the root cause of that interaction cannot be determined from the evidence available.Based on the visual examination of the delivery catheter, there is no indication that the reported events listed above were due to design or manufacture of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10741522
MDR Text Key213242040
Report Number2017233-2020-01383
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631032
UDI-Public00733132631032
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 12/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/29/2022
Device Model NumberGSX0030A
Device Catalogue NumberGSX0030A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2020
Initial Date Manufacturer Received 10/01/2020
Initial Date FDA Received10/27/2020
Supplement Dates Manufacturer Received10/01/2020
10/01/2020
Supplement Dates FDA Received11/04/2020
12/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age46 YR
Patient Weight76
-
-